Chris Holler

Chris Holler is a Principal Scientist in Discovery Biology at PepGen, with previous experience as a Principal Scientist at Arkuda Therapeutics, where significant contributions included profiling small molecule compounds and establishing high-content imaging lysosomal assays. Prior roles included Senior Scientist at Emory University, focusing on the progranulin protein's role in neurodegenerative diseases, and a series of research positions at the University of Kentucky, where research centered on Alzheimer's disease mechanisms. Chris's educational background includes a Ph.D. in Biochemistry and a Master’s in Bioprocess Engineering, both from the University of Kentucky and Virginia Tech, respectively. Notable achievements encompass multiple peer-reviewed publications and conference presentations, as well as involvement in academic collaborations and mentoring roles throughout various scientific positions.